此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Evaluation of Pcv-aCO2 in the Fluid Treatment of Abdominal Tumor Patients After Surgery

Clinical Study of Central Venous-to-Arterial Carbon Dioxide Difference(Pcv-aCO2) in the Evaluation of Fluid Therapy for Postoperative Patients With Abdominal Cancer

This research will confirm that Pcv-aCO2 is suitable for the guidance of early fluid therapy and the evaluation of the prognosis of patients with abnormal hemodynamics after abdominal tumor surgery, and is expected to be a new monitoring index to improve the therapeutic effect of these patients.

研究概览

详细说明

  1. Confirmed that Pcv-aCO2 is suitable for the guidance of early fluid therapy and the evaluation of the prognosis of patients with abnormal hemodynamics after abdominal tumor surgery, and is expected to be a new monitoring index to improve the therapeutic efficacy of this kind of patients.
  2. Pcv-aCO2 effectively reflected the improvement of tissue and organ microcirculation disorder through the individual goal target treatment to guide the fluid resuscitation in the hemodynamic instability patients.
  3. Research of the correlation between Pcv-aCO2 and the organ function in patients with abnormal hemodynamics after operation.

研究类型

介入性

注册 (预期的)

150

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Tianjin
      • Tianjin、Tianjin、中国、300060
        • 招聘中
        • Tianjin Medical University Cancer Institute and Hospital
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 65年 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  1. Acute physiology and chronic health score system II (APACHE II) score ≥10;
  2. Hemodynamic abnormalities post-operation (a. systolic blood pressure<90mmHg, or descent by basic blood pressure for more than 40mmHg. b. pulse pressure <20mmHg, c. urine volume <0.5ml/Kg/hr, d. heart rate >100 / min, e.Central Venous Pressure(CVP) <5mmHg, f. blood lactic acid >2.7mmol/L, meet any one above).
  3. Age ≥ 18 years, which is expected to stay in ICU for 5 days or longer;
  4. Patients themselves or their authorized clients agree to participate in clinical trials and signed informed consent.

Exclusion Criteria:

  1. age <18 years;
  2. without improvement in respiratory system disease or chronic obstructive pulmonary disease with Forced expiratory volume in one second (FEV1) <50%;
  3. lobectomy and pneumonectomy;
  4. death within 24 after treatment;
  5. patients with severe organ dysfunction;
  6. pregnant or lactating women;
  7. the patients did not sign informed consent;
  8. any factors that may be expected to increase the risk of patients or other factors that may interfere with the results of clinical trials.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
有源比较器:standard group

The patients with ScvO2 ≥ 70% will receive the conventional fluid therapy.than collect the data of ScvO2 and Pcv-aCO2:

ScvO2≥70%,and furthermore, Pcv-aCO2 is divided into "≤6mmHg" and ">6mmHg"

The patients with ScvO2 ≥ 70% will receive the conventional fluid therapy.
假比较器:control group

The patients with ScvO2 <70% will receive the standardized fluid therapy for 6 hours.than collect the data of ScvO2 and Pcv-aCO2:

ScvO2<70%,and furthermore, Pcv-aCO2 is divided into "≤6mmHg" and ">6mmHg"

The patients with ScvO2 <70% will receive the standardized fluid therapy for 6 hours.
其他名称:
  • Therapeutic effect of fluid resuscitation

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
The change of Pcv-aCO2
大体时间:fluid resuscitation for 6 hours, 12 hours and 24 hours
The change of Pcv-aCO2 (mmHg) after fluid resuscitation for 6 hours, 12 hours and 24 hours respectively.
fluid resuscitation for 6 hours, 12 hours and 24 hours

次要结果测量

结果测量
措施说明
大体时间
The treatment success rate in different groups
大体时间:Twenty-eighth days after admission
Collect the index of treatment success rate(%) of patients in different groups.
Twenty-eighth days after admission
The 28 day mortality in different groups
大体时间:Twenty-eighth days after admission
Collect the index of 28 day mortality(%) of patients in different groups.
Twenty-eighth days after admission
The hospitalization course in different groups
大体时间:Twenty-eighth days after admission
Collect the index of hospitalization course(days) of patients in different groups.
Twenty-eighth days after admission

其他结果措施

结果测量
措施说明
大体时间
The change of Central Venous Oxygen Saturation (ScvO2)
大体时间:fluid resuscitation for 6 hours, 12 hours and 24 hours
The change of Central venous oxygen saturation (ScvO2, %)after fluid resuscitation for 6 hours, 12 hours and 24 hours respectively.
fluid resuscitation for 6 hours, 12 hours and 24 hours
The change of hemoglobin (Hb)
大体时间:fluid resuscitation for 6 hours, 12 hours and 24 hours
The change of hemoglobin (Hb, g/L) after fluid resuscitation for 6 hours, 12 hours and 24 hours respectively.
fluid resuscitation for 6 hours, 12 hours and 24 hours
The change of blood lactic acid (Lac)
大体时间:fluid resuscitation for 6 hours, 12 hours and 24 hours
The change of blood lactic acid (Lac, mmol/L) after fluid resuscitation for 6 hours, 12 hours and 24 hours respectively.
fluid resuscitation for 6 hours, 12 hours and 24 hours
The change of Cardiac Index (CI)
大体时间:fluid resuscitation for 6 hours, 12 hours and 24 hours
The change of Cardiac Index (CI, L/(min•m^2)) after fluid resuscitation for 6 hours, 12 hours and 24 hours respectively.
fluid resuscitation for 6 hours, 12 hours and 24 hours
The Oxygen Supply status (DO2) in different groups
大体时间:fluid resuscitation for 6 hours, 12 hours and 24 hours
Collect the index of oxygen supply (DO2, ml/(min•m^2)) after fluid resuscitation for 6 hours, 12 hours and 24 hours respectively.
fluid resuscitation for 6 hours, 12 hours and 24 hours
The Oxygen Consumption (VO2) in different groups
大体时间:fluid resuscitation for 6 hours, 12 hours and 24 hours
Collect the index of oxygen consumption (VO2, ml/(min•m^2)) after fluid resuscitation for 6 hours, 12 hours and 24 hours respectively.
fluid resuscitation for 6 hours, 12 hours and 24 hours

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 研究主任:Wanhua Wang, director、Tianjin Medical University Cancer Institute and Hospital

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2016年10月1日

初级完成 (预期的)

2018年1月1日

研究完成 (预期的)

2018年9月1日

研究注册日期

首次提交

2016年10月9日

首先提交符合 QC 标准的

2016年11月27日

首次发布 (估计)

2016年11月30日

研究记录更新

最后更新发布 (估计)

2016年11月30日

上次提交的符合 QC 标准的更新

2016年11月27日

最后验证

2016年10月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

conventional fluid therapy的临床试验

3
订阅